Navigation Links
Cell Biosciences Announces First UK System Sale
Date:3/10/2009

PALO ALTO, Calif., March 10 /PRNewswire/ -- Cell Biosciences, Inc., a provider of nanoproteomic analysis systems to life science researchers, today announced the sale of its flagship protein analysis system to The University of Manchester's Stem Cell and Leukaemia Proteomics Laboratory, led by Professor Tony Whetton. Professor Whetton is a pioneer in the use of advanced proteomics technologies to understand biological processes in normal and leukaemic stem cells. The Cell Biosciences system will be used to study how phosphoprotein signaling processes in hematopoietic stem cells are affected during leukaemia.

"My laboratory has developed a number of new methods to look at changes in protein status within cells," said Professor Whetton. "We believe that the Cell Biosciences system will provide important new insights into the effect of leukaemogenic proteins on stem cell processes."

The Cell Biosciences platform is an ultrasensitive nanofluidic immunoassay system designed to analyze extremely small biological samples. Traditional protein analysis techniques can require as many as 100,000 cells, which complicates protein analysis in stem cells and other precious samples. Because of the Cell Biosciences system's high detection sensitivity, it can measure cell signaling proteins reproducibly in as few as 25 cells.

"The University of Manchester is an ideal location for our first UK placement," said Tim Harkness, President and Chief Executive Officer at Cell Biosciences. "We are pleased to see our products adopted by such a prestigious institution."

Cancer research in Manchester recently was rated best in the UK by the government-led Research Assessment Exercise (RAE), a comprehensive assessment of the quality of research at UK universities. The University of Manchester represents the second Cell Biosciences system sale in Europe.

About Cell Biosciences

Cell Biosciences is a private life sciences company focused on nanoproteomics. We develop instrumentation systems and assays for the measurement of phosphoprotein signaling and activation in extremely small biological samples. Our company's lead product is a capillary-based nanofluidic immunoassay platform that provides quantitative and reproducible data on key signaling pathways in precious biological samples, such as small tumor biopsies and stem cells. Cell Biosciences is located in Palo Alto, California.

www.cellbiosciences.com

info@cellbiosciences.com


'/>"/>
SOURCE Cell Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Regado Biosciences to Present at the 2009 Wharton Healthcare Business Conference
2. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2008 Results
3. Enlight Biosciences Expands to direct up to $52 Million to Transformational Enabling Technologies
4. New Jersey-Based Biotech Start-Up Nexomics Biosciences Gets Off the Ground
5. URMC, Lighthouse Biosciences Awarded U.S. Patent for Diagnostic Technology
6. URMC, Lighthouse Biosciences awarded US patent for diagnostic technology
7. Abbott Completes Acquisition of Ibis Biosciences, a Subsidiary of Isis
8. CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform
9. Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus
10. Alexander R. Giaquinto, Ph.D., Joins Regado Biosciences as Senior Vice President of Regulatory Affairs and Quality Assurance
11. Cell Biosciences Introduces First Protein Analysis Kits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... September 25, 2017 , ... Earlypicker is expanding its offerings to include fashion, ... hottest Korean cosmetics and fashion trends sweeping the nation. The decision to expand beyond ... the great offerings that allow Koreans everywhere to look their best every single day. ...
(Date:9/25/2017)... ... September 25, 2017 , ... “Grandpa's Visit”: a ... teach and share with the others. “Grandpa's Visit” is the creation of published author, ... that she is much like the character in her book. She shares, “Mr. Rice ...
(Date:9/25/2017)... CA (PRWEB) , ... September 25, 2017 , ... Azadian ... a full-time office in downtown Los Angeles, to service existing clients in the Western ... areas. , “We are seeing an ever-increasing amount of business demand west of the ...
(Date:9/24/2017)... ... September 25, 2017 , ... Bhowanie Benimadhu’s new book “ Our Creative World: ... life and seeks answers in both Eastern and Western religious traditions and spirituality such ... in the mind of humankind for the past thousands of years and still are,” ...
(Date:9/24/2017)... Turks & Caicos Islands, BWI (PRWEB) , ... September 24, 2017 ... ... Islands, the #1 rated resort on TripAdvisor and one of Provo's premier boutique resorts, ... no reported structural damage to the resort after devastating Hurricanes Irma and more recently ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting at ... Rodman & Renshaw 19 th Annual Global Investment Conference ... p.m. Pacific time). The conference is being held at the ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
(Date:9/5/2017)... Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ORMP) ... the development of oral drug delivery systems, announced today ... U.S. Food and Drug Administration (FDA) regarding ORMD-0801, the ... At the meeting, the FDA gave clear ... would be a Biologics License Application (BLA).  Such a ...
Breaking Medicine Technology: